Burning Rock Biotech (BNR) Gross Margin: 2020-2025
Historic Gross Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 75.07%.
- Burning Rock Biotech's Gross Margin rose 381.00% to 75.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.12%, marking a year-over-year increase of 439.00%. This contributed to the annual value of 70.25% for FY2024, which is 267.00% up from last year.
- As of Q3 2025, Burning Rock Biotech's Gross Margin stood at 75.07%, which was up 3.16% from 72.77% recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Gross Margin ranged from a high of 75.07% in Q3 2025 and a low of 63.03% during Q2 2022.
- Moreover, its 3-year median value for Gross Margin was 70.43% (2024), whereas its average is 70.19%.
- Per our database at Business Quant, Burning Rock Biotech's Gross Margin plummeted by 787bps in 2022 and then skyrocketed by 624bps in 2024.
- Over the past 5 years, Burning Rock Biotech's Gross Margin (MRQ) stood at 71.52% in 2021, then decreased by 1bps to 70.78% in 2022, then fell by 8bps to 64.85% in 2023, then increased by 10bps to 71.09% in 2024, then grew by 6bps to 75.07% in 2025.
- Its Gross Margin was 75.07% in Q3 2025, compared to 72.77% in Q2 2025 and 73.18% in Q1 2025.